Back
ESC Professional Premium Access

Bivalirudin versus Heparin in ST and non-ST-segment elevation myocardial infarction

Session: Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon
Topic: Adjunctive Pharmacotherapy
Speaker: Professor E. Omerovic (Gothenburg, SE)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)
13 presentations
0 follower

4 more presentations in this session

State-of-the-art lecture beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon

Speaker: Professor S. Nicholls (Melbourne, AU)

Access
Slides
Video
Thumbnail

P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis

Speaker: Professor J. Silvain (Paris, FR)

Access
Abstract
Slides
Video
Thumbnail

Lipid lowering treatment after percutaneous coronary intervention: data from the large contemporary ZON-HR registry.

Speaker: Ms E. Woelders (Nijmegen, NL)

Access
Abstract
Slides
Video
Thumbnail

Successful ESC recommended LDL-C reduction after percutaneous coronary intervention: real-world data from the contemporary ZON-HR registry.

Speaker: Ms D. Peeters (Nijmegen, NL)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon

Speakers: Professor E. Omerovic, Professor S. Nicholls, Professor J. Silvain, Ms E. Woelders, Ms D. Peeters
Access
Video
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb